Regeneron’s Ebola treatment proves superior to rival in trial

Regeneron Pharmaceuticals Inc said on Monday its experimental treatment for Ebola proved superior to a rival therapy from Mapp Biopharmaceutical at preventing death, in a trial evaluating four treatments for infections caused by the deadly virus. Reuters Health News

Leave a Reply

Time limit is exhausted. Please reload CAPTCHA.